Who makes escitalopram and eszopiclone?

escitalopram and eszopiclone is developed by University of California, Los Angeles.

What development phase is escitalopram and eszopiclone in?

escitalopram and eszopiclone is FDA-approved (marketed).

Last reviewed 2026-05-14 · How we verify

escitalopram and eszopiclone

University of California, Los Angeles · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	escitalopram and eszopiclone
Also known as	Lexapro, Lunesta
Sponsor	University of California, Los Angeles
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia (PHASE4)
Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder (PHASE4)
Brain Mechanisms and Targeting Insomnia in Major Depression (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

escitalopram and eszopiclone CI brief — competitive landscape report
escitalopram and eszopiclone updates RSS · CI watch RSS
University of California, Los Angeles portfolio CI